A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice.
about
Cell therapy for the diseased liver: from stem cell biology to novel models for hepatotropic human pathogensTransfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma developmentAmplification of engrafted hepatocytes by preparative manipulation of the host liver.Over-expression of miR-106b promotes cell migration and metastasis in hepatocellular carcinoma by activating epithelial-mesenchymal transition processMortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapyTargeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinomaHepatitis B virus infection of transplanted human hepatocytes causes a biochemical and histological hepatitis in immunocopetentent ratsTensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinomaTransplantation of human hepatocytes into tolerized genetically immunocompetent ratsStrategies for immortalization of primary hepatocytesImmortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.Full-length Mst1 exhibits growth promoting function in human hepatocellular carcinoma cells.Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication.CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.Lupeol targets liver tumor-initiating cells through phosphatase and tensin homolog modulation.Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133.Enzymatically labeled chromosomal probes for in situ identification of human cells in xenogeneic transplant models.Human hepatocytes transplanted into genetically immunocompetent rats are susceptible to infection by hepatitis B virus in situ.Complex HBV populations with mutations in core promoter, C gene, and pre-S region are associated with development of cirrhosis in long-term renal transplant recipients
P2860
Q27487009-BD805775-2D08-4EEC-8F03-573F9EEDA41AQ33851759-3B8CCD93-04A2-4316-A53D-B8CBA65BC8E6Q33988586-9F9E31F6-EC75-4640-9127-ACC2E92C599DQ34329968-E71AC3AE-539D-4501-8C4E-A55F894AA2A4Q34618415-7521A6E5-7873-40BA-84FE-1F0EBCDA0059Q35092706-93D114F5-B3CC-4D2D-A7E0-DCCA1AD13B95Q35893965-29EE370F-B989-434E-9DAF-71FC97836F5CQ36178571-DF735FA5-6AD4-416C-A1E8-DE625483AE18Q36356211-2560A96E-C151-47A2-A893-04CC1B695AFBQ36397368-50522A9C-0A82-416B-87D5-114ADE1F14A7Q38218749-269A6307-D537-4E20-9147-4C3928C83F7EQ38843888-8FFB6F86-8A75-468F-9530-8B1298AB946CQ39205350-F96E22AA-F119-4EA6-9361-7603091D0D16Q39277056-A497C737-786B-4122-A70E-94AE88D28007Q39459026-52CCC3D6-ADEC-4263-B575-FB73101C730DQ39639351-78398272-0516-45DC-BE4A-510890DEA674Q41773876-14C75993-8286-4A41-8B07-7A935F1E2F85Q44107434-52F8D2F7-E1A6-4FD6-B3FC-EF7589AC3B70Q44201425-F879733A-93B2-4D9E-B649-30BF48F19578Q56439428-312508CA-0135-4B97-B4A1-3D7FEECC7003
P2860
A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in Rag-2-deficient mice.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
A long-term hepatitis B viremi ...... cytes in Rag-2-deficient mice.
@en
type
label
A long-term hepatitis B viremi ...... cytes in Rag-2-deficient mice.
@en
prefLabel
A long-term hepatitis B viremi ...... cytes in Rag-2-deficient mice.
@en
P2093
P356
P1433
P1476
A long-term hepatitis B viremi ...... cytes in Rag-2-deficient mice.
@en
P2093
Engelhardt D
Parashar B
Roy-Chowdhury J
Roy-Chowdhury N
P2860
P304
P356
10.1002/HEP.510310126
P407
P577
2000-01-01T00:00:00Z